J. Goldman & Co LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$3,199,000
+241.8%
90,276
+85.4%
0.20%
+273.6%
Q1 2019$936,000
-83.2%
48,700
-87.5%
0.05%
-87.6%
Q4 2018$5,558,000
+664.5%
389,536
+649.1%
0.43%
+1059.5%
Q3 2017$727,000
-68.3%
52,000
-80.0%
0.04%
-70.2%
Q2 2017$2,296,000
+36.5%
260,0000.0%0.12%
+49.4%
Q1 2017$1,682,000
-59.7%
260,000
-77.1%
0.08%
-69.9%
Q4 2016$4,169,000
-24.4%
1,136,000
-33.0%
0.28%
-11.3%
Q3 2016$5,514,0001,696,6990.31%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders